EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+53.9%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$730M
AUM Growth
+$730M
(+68%)
Cap. Flow
+$162M
Cap. Flow
% of AUM
22.21%
Top 10 Holdings %
Top 10 Hldgs %
75.34%
Holding
50
New
15
Increased
11
Reduced
5
Closed
10
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$40M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$29.6M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$26.9M |
| 4 |
Kura Oncology
KURA
|
$25.9M |
| 5 |
Ascendis Pharma
ASND
|
$22.7M |
Top Sells
| 1 |
Sangamo Therapeutics
SGMO
|
$35.2M |
| 2 |
Galapagos
GLPG
|
$34.4M |
| 3 |
Editas Medicine
EDIT
|
$12M |
| 4 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$4.52M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$3.41M |
Sector Composition
| 1 | Healthcare | 90.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Assembly Biosciences
ASMB
$190M
| $103M | 13.7% | 2,943,164 | – | – |
|
2
FibroGen
FGEN
$47.8M
| $93.4M | 12.45% | 1,735,677 +150,220 | +9% | +$8.08M |
|
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $86.1M | 11.47% | 5,459,583 +1,705,948 | +45% | +$26.9M |
|
|
4
Ascendis Pharma
ASND
$11.8B
| $76.4M | 10.18% | 2,107,600 +625,000 | +42% | +$22.7M |
|
|
5
Kura Oncology
KURA
$686M
| $56.3M | 7.51% | 3,766,852 +1,733,230 | +85% | +$25.9M |
|
|
IMMU
6
DELISTED
Immunomedics Inc
IMMU
| $40M | 5.33% | +2,860,019 | New | +$40M |
|
|
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $29.6M | 3.94% | +689,986 | New | +$29.6M |
|
|
8
Galapagos
GLPG
$2.07B
| $24.5M | 3.27% | 240,776 -337,729 | -58% | -$34.4M |
|
|
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $21.3M | 2.83% | +3,622,271 | New | +$21.3M |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $19.9M | 2.65% | 3,934,849 +1,642,190 | +72% | +$8.29M |
|
11
Forte Biosciences
FBRX
$137M
| $18.7M | 2.49% | 1,502,373 | – | – |
|
|
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
| $15.4M | 2.05% | +1,250,000 | New | +$15.4M |
|
13
CytomX Therapeutics
CTMX
$336M
| $15.1M | 2.01% | 829,771 +34,802 | +4% | +$632K |
|
14
Corvus Pharmaceuticals
CRVS
$428M
| $14.5M | 1.93% | 908,525 +103,525 | +13% | +$1.65M |
|
15
Indaptus Therapeutics
INDP
$7.19M
| $13.4M | 1.79% | +1,500,000 | New | +$13.4M |
|
16
Insmed
INSM
$28.8B
| $12.7M | 1.69% | +405,400 | New | +$12.7M |
|
17
Wave Life Sciences
WVE
$1.53B
| $12.3M | 1.64% | +564,248 | New | +$12.3M |
|
|
CASC
18
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $12.3M | 1.64% | 3,000,000 | – | – |
|
19
Omeros
OMER
$283M
| $9.73M | 1.3% | +450,000 | New | +$9.73M |
|
20
Fate Therapeutics
FATE
$120M
| $8.96M | 1.19% | 2,262,678 -274,348 | -11% | -$1.09M |
|
|
RGLS
21
DELISTED
Regulus Therapeutics
RGLS
| $6.55M | 0.87% | 5,239,225 +1,530,081 | +41% | +$1.91M |
|
|
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.51M | 0.73% | 957,992 +190,000 | +25% | +$1.09M |
|
23
Tempest Therapeutics
TPST
$44M
| $4.99M | 0.66% | 3,512,332 | – | – |
|
24
Zai Lab
ZLAB
$3.68B
| $4.31M | 0.57% | +159,535 | New | +$4.31M |
|
|
KIN
25
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.28M | 0.57% | 544,880 | – | – |
|